Literature DB >> 11264343

Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection.

L C Spender1, G H Cornish, B Rowland, B Kempkes, P J Farrell.   

Abstract

We have studied the pathways of regulation of cytokine and cell cycle control proteins during infection of human B lymphocytes by Epstein-Barr virus (EBV). Among 30 cytokine RNAs analyzed by the RNase protection assay, tumor necrosis factor alpha (TNF-alpha), granulocyte colony-stimulating factor, lymphotoxin (LT), and LTbeta were found to be regulated within 20 h of EBV infection of primary B cells. Similar results were obtained using the estrogen-regulated EBNA-2 cell line EREB2.5, in which RNAs for LT and TNF-alpha were induced within 6 h of activation of EBNA-2. Expression of Notch also caused an induction of TNF-alpha RNA. The induction of TNF-alpha RNA by EBNA-2 was indirect, and constitutive expression of either LMP-1 or c-myc proteins did not substitute for EBNA-2 in induction of TNF-alpha RNA. Cyclin D2 is also an indirect target of EBNA-2-mediated transactivation. EBNA-2 was found to activate the cyclin D2 promoter in a transient-transfection assay. A mutant of EBNA-2 that does not bind RBP-Jkappa retained some activity in this assay, and activation did not depend on the presence of B-cell-specific factors. Deletion analysis of the cyclin D2 promoter revealed that removal of sequences containing E-box c-myc consensus DNA binding sequences did not reduce EBNA-2-mediated activation of the cyclin D2 promoter in the transient-transfection assay. The results indicate that cytokines are an early target of EBNA-2 and that EBNA-2 can regulate cyclin D2 transcription in EBV-infected cells by mechanisms additional to the c-myc pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264343      PMCID: PMC114845          DOI: 10.1128/JVI.75.8.3537-3546.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP.

Authors:  Y Kawaguchi; K Nakajima; M Igarashi; T Morita; M Tanaka; M Suzuki; A Yokoyama; G Matsuda; K Kato; M Kanamori; K Hirai
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription.

Authors:  M E Greenberg; A L Hermanowski; E B Ziff
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

3.  Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.

Authors:  K P Mann; D Staunton; D A Thorley-Lawson
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

4.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.

Authors:  H A Coller; C Grandori; P Tamayo; T Colbert; E S Lander; R N Eisenman; T R Golub
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

5.  Cell cycle activation by c-myc in a burkitt lymphoma model cell line.

Authors:  A Pajic; D Spitkovsky; B Christoph; B Kempkes; M Schuhmacher; M S Staege; M Brielmeier; J Ellwart; F Kohlhuber; G W Bornkamm; A Polack; D Eick
Journal:  Int J Cancer       Date:  2000-09-15       Impact factor: 7.396

6.  Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2.

Authors:  D Y Wu; A Krumm; W H Schubach
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis.

Authors:  G A Parker; R Touitou; M J Allday
Journal:  Oncogene       Date:  2000-02-03       Impact factor: 9.867

8.  DNA binding of USF is required for specific E-box dependent gene activation in vivo.

Authors:  A Kiermaier; J M Gawn; L Desbarats; R Saffrich; W Ansorge; P J Farrell; M Eilers; G Packham
Journal:  Oncogene       Date:  1999-12-02       Impact factor: 9.867

9.  Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75).

Authors:  H Ben-Bassat; N Goldblum; S Mitrani; T Goldblum; J M Yoffey; M M Cohen; Z Bentwich; B Ramot; E Klein; G Klein
Journal:  Int J Cancer       Date:  1977-01       Impact factor: 7.396

10.  B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2.

Authors:  B Kempkes; D Spitkovsky; P Jansen-Dürr; J W Ellwart; E Kremmer; H J Delecluse; C Rottenberger; G W Bornkamm; W Hammerschmidt
Journal:  EMBO J       Date:  1995-01-03       Impact factor: 11.598

View more
  24 in total

1.  Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter.

Authors:  Wei Yue; Edward Gershburg; Joseph S Pagano
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent.

Authors:  Sabine Maier; Maja Santak; Anja Mantik; Kristina Grabusic; Elisabeth Kremmer; Wolfgang Hammerschmidt; Bettina Kempkes
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Cellular target genes of Epstein-Barr virus nuclear antigen 2.

Authors:  Sabine Maier; Gabriele Staffler; Andrea Hartmann; Julia Höck; Karen Henning; Kristina Grabusic; Reinhard Mailhammer; Reinhard Hoffmann; Matthias Wilmanns; Roland Lang; Jörg Mages; Bettina Kempkes
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.

Authors:  Sophia Spadavecchia; Olga Gonzalez-Lopez; Kyla Driscoll Carroll; Diana Palmeri; David M Lukac
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

5.  Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis, and apoptosis-related proteins in gastric carcinoma.

Authors:  Yun Wang; Bing Luo; Li-Ping Yan; Bao-Hua Huang; Peng Zhao
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

6.  Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1.

Authors:  Sungwook Lee; Shuhei Sakakibara; Seiji Maruo; Bo Zhao; Michael A Calderwood; Amy M Holthaus; Chiou-Yan Lai; Kenzo Takada; Elliott Kieff; Eric Johannsen
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

7.  Cellular transcripts regulated during infections with Highly Pathogenic H5N1 Avian Influenza virus in 3 host systems.

Authors:  Vinod Rmt Balasubramaniam; Sharifah S Hassan; Abdul R Omar; Maizan Mohamed; Suriani M Noor; Ramlan Mohamed; Iekhsan Othman
Journal:  Virol J       Date:  2011-04-29       Impact factor: 4.099

8.  Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.

Authors:  Shunbin Ning; Angela M Hahn; Leslie E Huye; Joseph S Pagano
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation.

Authors:  Sarah E Blutt; Sue E Crawford; Kelly L Warfield; Dorothy E Lewis; Mary K Estes; Margaret E Conner
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function.

Authors:  Wei Yue; Matthew G Davenport; Julia Shackelford; Joseph S Pagano
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.